4.6 Article

Ethics of sham surgery: Perspective of patients

期刊

MOVEMENT DISORDERS
卷 23, 期 1, 页码 63-68

出版社

WILEY-LISS
DOI: 10.1002/mds.21775

关键词

sham surgery; Parkinson's disease; placebo controlled trials; gene therapy

资金

  1. NCRR NIH HHS [1 UL1 RR024160-01, UL1 RR024160] Funding Source: Medline
  2. NIMH NIH HHS [K23 MH64172] Funding Source: Medline
  3. NINDS NIH HHS [K24 NS42098, U54-NS45309] Funding Source: Medline

向作者/读者索取更多资源

Sham surgery is used as a control condition in neurosurgical clinical trials in Parkinson's disease (PD) but remains controversial. This study aimed to assess the perspective of patients with PD and the general public on the use of sham surgery controls. We surveyed consecutive patients from a university-based neurology outpatient clinic and a community-based general internal medicine practice. Background information was provided regarding PD and two possible methods of testing the efficacy of a novel gene transfer procedure, followed by questions that addressed participants' opinions related to the willingness to participate and permissibility of blinded and unblinded trial designs. Two hundred eighty-eight (57.6%) patients returned surveys. Patients with PD expressed less willingness to participate in the proposed gene transfer surgery trials. Unblinded studies received greater support, but a majority would still allow the use of sham surgery. Those in favor of sham surgery were more educated and more likely to use societal perspective rationales. Patients with PD are more cautious about surgical research participation than patients with non-PD. Their policy views were similar to others', with a majority supporting the use of sham controls. Future research needs to determine whether eliciting more considered judgments of laypersons would reveal different levels of support for sham surgery. (c) 2007 Movement Disorder Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据